Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in creating active pharmaceutical ingredients (APIs) that target specific signaling pathways in oncology. Its structure allows for selective modification, enabling optimization of drug potency and selectivity. Commonly employed in research and development of small molecule therapeutics for targeted therapy.